Mikhail Blagosklonny is a well known and accomplished Scientist that has devoted his career and profession to the study of Aging as well as Cancer. Presently, Mikhail Blagosklonny is on staff as a Professor of Oncology at Roswell Park Cancer Institute. The Roswell Cancer Institute is located in New York.
*Educational Background/ Area of Concentration:
Mikhail Blagosklonny graduated from the First Pavlov State Medical University. The University is located within the Saint Pettersburg area of Florida. Mikhail Blagosklonny received both is MD as well as his PHD from First Pavlov Medical University. His primary area of study was on Experimental Medicine techniques as well as studies involving the heart and circulatory system (Cardiology).
Part of Mikhail Blagosklonny work experience involves being appointed Associate Professor of Medicine at New York Medical College. It was during his tenure with New York Medical College that the Doctor developed an interest in researching as well as studying Cancer and the aging process.
After his experience as Associate Professor of Medicine, Mikhail Blagosklonny accepted a position as a Research Scientist at the Ordway Scientific and Research Institute. Blagosklonny became involved in various research projects while at Ordway. He held the position as Associate Professor of Medicine at Ordway Institute for a period of seven years.
After resigning from Ordway, Mikhail Blagosklonny accepted a position as Professor of Oncology at the Roswell Cancer Institute. Dr. Blagosklonny began intensive research which involved Cancer studies. In addition, Mikhail Blagosklonny began to research the aging process and the possibility of altering or slowing the process of aging. His studies seemed to both fascinate as well as intrigue staff members.
Mikhail Blagosklonny main area of study was on Cancer treatments that left healthy cell unharmed. In addition, his fascination with turning back the hands of time as far as aging was concerned seemed to dominate his research ideas and studies. Dr. Blagosklonny discovered that TOR Signaling played a definite role in the aging process.
*Anti-aging Studies/ Publications:
During the course of Mikhail Blagosklonny’s anti-aging studies he discovered that the drug Rapamycin could possibly extend ones life dramatically. Rapamycin was commonly used as a Cancer drug however, Dr. Blagosklonny felt it could be useful in reversing as well as altering the process of aging. He is a firm believer that Rapamycin should be used in research studies involving longevity and anti-aging. However, as expected Mikhail Blagosklonny received much opposition for his research ideas for a variety of reasons.
Mikhail Blagosklonny has written several medical publications. In addition, he has co-authored the books “Cell Cycle” as well as “Cancer Biology & Therapy”. He is also a regular member of the Medical Editorial Board of “Cell Death and Differentiation”. Dr. Blagosklonny has also spoken at several medical conferences on a national level.